301 related articles for article (PubMed ID: 18855877)
21. Fine-needle aspiration features of extraskeletal myxoid chondrosarcoma: A study of cytological and molecular features.
Santos F; Martins C; Lemos MM
Diagn Cytopathol; 2018 Nov; 46(11):950-957. PubMed ID: 30353688
[TBL] [Abstract][Full Text] [Related]
22. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator.
Labelle Y; Bussières J; Courjal F; Goldring MB
Oncogene; 1999 May; 18(21):3303-8. PubMed ID: 10359536
[TBL] [Abstract][Full Text] [Related]
23. Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.
Urbini M; Indio V; Astolfi A; Tarantino G; Renne SL; Pilotti S; Dei Tos AP; Maestro R; Collini P; Nannini M; Saponara M; Murrone L; Dagrada GP; Colombo C; Gronchi A; Pession A; Casali PG; Stacchiotti S; Pantaleo MA
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937513
[TBL] [Abstract][Full Text] [Related]
24. Intra-articular Extraskeletal EWSR1-Negative NR4A3-Positive Myxoid Chondrosarcoma: A Case Report.
Lal DN; El-Zammar O; Naous R; Damron TA
JBJS Case Connect; 2020; 10(2):e0614. PubMed ID: 32649120
[TBL] [Abstract][Full Text] [Related]
25. Extraskeletal myxoid chondrosarcoma of the vulva with PLAG1 gene activation: molecular genetic characterization of 2 cases.
Dotlic S; Gatalica Z; Wen W; Ghazalpour A; Mangham C; Babic D; Zekan J; Vranic S
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):537-42. PubMed ID: 24185117
[TBL] [Abstract][Full Text] [Related]
26. Keratin-positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour.
Sugino H; Iwata S; Satomi K; Mori T; Nobusawa S; Nagashima T; Matsushita Y; Yatabe Y; Ichimura K; Kawai A; Yoshida A
Histopathology; 2023 May; 82(6):937-945. PubMed ID: 36754860
[TBL] [Abstract][Full Text] [Related]
27. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
[TBL] [Abstract][Full Text] [Related]
28. Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein.
Poulin H; Filion C; Ladanyi M; Labelle Y
Biochem Biophys Res Commun; 2006 Jul; 346(1):306-13. PubMed ID: 16756948
[TBL] [Abstract][Full Text] [Related]
29. INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.
Yoshida A; Makise N; Wakai S; Kawai A; Hiraoka N
Mod Pathol; 2018 May; 31(5):744-752. PubMed ID: 29327709
[TBL] [Abstract][Full Text] [Related]
30. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.
Noujaim J; Jones RL; Swansbury J; Gonzalez D; Benson C; Judson I; Fisher C; Thway K
Br J Cancer; 2017 Feb; 116(5):669-678. PubMed ID: 28141799
[TBL] [Abstract][Full Text] [Related]
31. The gene expression profile of extraskeletal myxoid chondrosarcoma.
Subramanian S; West RB; Marinelli RJ; Nielsen TO; Rubin BP; Goldblum JR; Patel RM; Zhu S; Montgomery K; Ng TL; Corless CL; Heinrich MC; van de Rijn M
J Pathol; 2005 Aug; 206(4):433-44. PubMed ID: 15920699
[TBL] [Abstract][Full Text] [Related]
32. EWSR1::NR4A3 gene fusion in a cutaneous atypical myoepithelial neoplasm.
Scholl AR; Kliassov E; Cardona DM; Bentley R; Al-Rohil RN
J Cutan Pathol; 2023 Jul; 50(7):601-605. PubMed ID: 37057374
[TBL] [Abstract][Full Text] [Related]
33. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
35. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):293-299. PubMed ID: 32828707
[TBL] [Abstract][Full Text] [Related]
36. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).
Sjögren H; Wedell B; Meis-Kindblom JM; Kindblom LG; Stenman G
Cancer Res; 2000 Dec; 60(24):6832-5. PubMed ID: 11156374
[TBL] [Abstract][Full Text] [Related]
37. Differential transactivation by orphan nuclear receptor NOR1 and its fusion gene product EWS/NOR1: possible involvement of poly(ADP-ribose) polymerase I, PARP-1.
Ohkura N; Nagamura Y; Tsukada T
J Cell Biochem; 2008 Oct; 105(3):785-800. PubMed ID: 18680143
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.
Attwooll C; Tariq M; Harris M; Coyne JD; Telford N; Varley JM
Oncogene; 1999 Dec; 18(52):7599-601. PubMed ID: 10602520
[TBL] [Abstract][Full Text] [Related]
39. Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion, resembling extraskeletal myxoid chondrosarcoma: Case report with a review of Literature.
Matsukuma S; Hisaoka M; Obara K; Kono T; Takeo H; Sato K; Hata Y
Pathol Int; 2012 Dec; 62(12):817-22. PubMed ID: 23252871
[TBL] [Abstract][Full Text] [Related]
40. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
